|
Appropriate to do lasso, then standard glm using variables with non-zero coef. from lasso?
|
|
1
|
935
|
July 2, 2024
|
|
Estimands from zero-inflated regression model
|
|
9
|
1663
|
June 20, 2024
|
|
ITT analysis under equally high non-adherence in both arms in RCT
|
|
4
|
1059
|
June 9, 2024
|
|
Can we think of competing-event as another form of non-event in terms of utility?
|
|
0
|
1080
|
April 21, 2024
|
|
Is Lithium Equivalent to Lecanemab in Slowing cognitive decline in Alzheimer's Disease?
|
|
0
|
1123
|
February 23, 2024
|
|
Review of Trial at the Center of the Firestorm Over Early Connection of Patients to Ventilators during the Pandemic
|
|
34
|
5751
|
February 16, 2024
|
|
Does subtracting/or not, the mean-rank in Wilcoxon-Mann-Whitney make any difference?
|
|
4
|
1230
|
February 1, 2024
|
|
Ranked analysis of ANCOVA
|
|
7
|
3283
|
January 21, 2024
|
|
AUC of each subgroup is smaller than overall AUC
|
|
7
|
5773
|
November 13, 2023
|
|
Interpreting Survival Probability in Relation to 'Number at Risk' and Median Follow-Up Times
|
|
2
|
1803
|
October 3, 2023
|
|
About the interpret category
|
|
1
|
3424
|
October 3, 2023
|
|
Comparing "all active dose" to placebo - do we treat "all active dose" as one group or separate groups?
|
|
2
|
1110
|
September 4, 2023
|
|
Guidance of analysis of longitudinal patient reported outcomes w.r.t Joint models
|
|
4
|
1741
|
August 29, 2023
|
|
Design of Experiments in Economics vs Medicine: a Decision Theory POV
|
|
6
|
2868
|
July 27, 2023
|
|
Inferences from summary data - without seeing the data for a Cox PH model, do chi square tests tell us anything?
|
|
5
|
671
|
July 24, 2023
|
|
Case-control study with and corresponding subgroup
|
|
2
|
1014
|
July 20, 2023
|
|
Impact of Model Intercepts on Ordinal Logistic Regression Outcome
|
|
7
|
2792
|
June 22, 2023
|
|
P values and small sample size
|
|
6
|
1514
|
June 20, 2023
|
|
Minimum PPV/NPV values to reach positive net benefit and net benefit avoided
|
|
10
|
1828
|
June 12, 2023
|
|
Outlier detection
|
|
3
|
1886
|
May 11, 2023
|
|
HR really close to 1 but significant - how to interpret and report?
|
|
9
|
2291
|
April 25, 2023
|
|
FDA "Bad Habits"
|
|
7
|
2563
|
March 4, 2023
|
|
Advice regarding a Directed Acyclic Graph and further analysis Plan
|
|
7
|
2472
|
January 22, 2023
|
|
R package to present summary results from many different mixed effects models
|
|
3
|
1605
|
December 28, 2022
|
|
Interpretation of subject-specific effect in a cross-over study
|
|
5
|
4164
|
November 28, 2022
|
|
Generalized Additive Models with R gam
|
|
1
|
2164
|
November 22, 2022
|
|
Information, Evidence, and Statistics for critical research appraisal
|
|
17
|
4090
|
November 21, 2022
|
|
Categorization of continuous outcome and odds ratio
|
|
2
|
1035
|
November 8, 2022
|
|
Interactions and random error
|
|
24
|
12241
|
October 20, 2022
|
|
Statistics Applied Using Threshold Science Fails to Deliver Progression Toward Truth
|
|
2
|
3409
|
September 23, 2021
|